ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket20128418-24ketendo-4452Research ArticleСтатьиArticlesТерминологические и классификационные аспекты Бетестовской системыклассифицирования цитологических заключений щитовидной железыTerminology and classification aspects of the Bethesda System for Reporting Thyroid CytopathologySemkinaG V-AbdulhabirovaF M-SmirnovaV A-VanushkoV E-20121512201284ТОМ 8, №4 (2012)1824Copyright © Semkina G.V., Abdulhabirova F.M., Smirnova V.A., Vanushko V.E., 20122012Semkina G.V., Abdulhabirova F.M., Smirnova V.A., Vanushko V.E.Semkina G.V., Abdulhabirova F.M., Smirnova V.A., Vanushko V.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/4452

Статья посвящена возможностям применения Бетестовской системы интерпретации результатов тонкоигольной аспирационной биопсии (ТАБ). Представлены современные данные об основных отличиях, а также преимуществах новой классификации. Применение Бетестовской системы классифицирования приводит к повышению чувствительности и специфичности ТАБ

The article is devoted to the relevance of Betesda System for Reporting Thyroid Cytopathology. This article summarizes recent data on the main differences and advantages of new classification system. Application of the Betesda System for Reporting Thyroid Cytopathology leads to the increased sensitivity and specificity of FNA.

щитовидная железаТАБцитологическое заключениеthyroidFNAcytologic diagnosisReferencesAbele J.S., Levine R.A. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010; 118: 415–422. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrinol. Pract. 2006; 12: 63–103.Abele J.S., Levine R.A. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010; 118: 415–422. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrinol. Pract. 2006; 12: 63–103.Baloch Z.W., Livolsi V.A., Asa S.L. et al. Diagnostic terminology and morphological criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine- needle aspiration state of the science conference. Diagn. Cytopathol. 2008; 36: 425–433.Baloch Z.W., Livolsi V.A., Asa S.L. et al. Diagnostic terminology and morphological criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine- needle aspiration state of the science conference. Diagn. Cytopathol. 2008; 36: 425–433.Caraci P., Aversa S., Mussa A. et al. Role of fineneedle aspiration biopsy and frozen-section evaluation in the surgical management of thyroid nodules. Br. J. Surg. 2002; 89: 797–701.Caraci P., Aversa S., Mussa A. et al. Role of fineneedle aspiration biopsy and frozen-section evaluation in the surgical management of thyroid nodules. Br. J. Surg. 2002; 89: 797–701.Cibas E.S., Alexander E.K., Benson C.B. et al. Indications for Thyroid FNA and Pre-FNA Requirements: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 390–399.Cibas E.S., Alexander E.K., Benson C.B. et al. Indications for Thyroid FNA and Pre-FNA Requirements: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 390–399.Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2009; 132: 658–665.Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2009; 132: 658–665.Cooper D.S., Doherty G.M., Haugen B.R. et al. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Taskforce. Thyroid. 2006; 16: 1–33.Cooper D.S., Doherty G.M., Haugen B.R. et al. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Taskforce. Thyroid. 2006; 16: 1–33.Duek S.D., Goldenberg D., Linn S. et al. The role of fineneedle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg. Today. 2002; 32: 857–861.Duek S.D., Goldenberg D., Linn S. et al. The role of fineneedle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg. Today. 2002; 32: 857–861.Jo V.Y., Van der Laan P.A., Marqusee E., Krane J.F. Repeatedly Nondiagnostic Thyroid Fine-Needle Aspirations Do Not Modify Malignancy Risk. Acta Cytol. 2011; 55: 539–543.Jo V.Y., Van der Laan P.A., Marqusee E., Krane J.F. Repeatedly Nondiagnostic Thyroid Fine-Needle Aspirations Do Not Modify Malignancy Risk. Acta Cytol. 2011; 55: 539–543.Koen T.M., Mody D.R., Scheiber-Pacht M. et al. Limiting the use of atypical/inconclusive as a category in nongynecologic cytology specimens. Arch. Pathol. Lab. Med. 2010; 134: 1016–1019.Koen T.M., Mody D.R., Scheiber-Pacht M. et al. Limiting the use of atypical/inconclusive as a category in nongynecologic cytology specimens. Arch. Pathol. Lab. Med. 2010; 134: 1016–1019.Luu M.H., Fischer A.H., Stockl T.J. et al. Atypical Follicular Cells with Equivocal Features of Papillary Thyroid Carcinoma Is Not a Low-Risk Cytologic Diagnosis. Acta Cytol. 2011; 55: 526–530.Luu M.H., Fischer A.H., Stockl T.J. et al. Atypical Follicular Cells with Equivocal Features of Papillary Thyroid Carcinoma Is Not a Low-Risk Cytologic Diagnosis. Acta Cytol. 2011; 55: 526–530.Marchevsky A.M., Walts A.E., Bose S. et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn. Cytopathol. 2010; 38: 252–259.Marchevsky A.M., Walts A.E., Bose S. et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn. Cytopathol. 2010; 38: 252–259.Nayar R., Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009; 117: 195–202.Nayar R., Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009; 117: 195–202.NCI Thyroid Fine Needle Aspiration State of Science Conference. Diagn. Cytopathol. 2008; 6: 388–448.NCI Thyroid Fine Needle Aspiration State of Science Conference. Diagn. Cytopathol. 2008; 6: 388–448.Ohori N.P., Schoedel K.E. Variability in the Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations. Acta Cytol. 2011; 55: 492–498.Ohori N.P., Schoedel K.E. Variability in the Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations. Acta Cytol. 2011; 55: 492–498.Olson M.T., Clark D.P., Erozan Y.S., Ali S.Z. Spectrum of Risk of Malignancy in Subcategories of ‘Atypia of Undetermined Significance’. Acta Cytol. 2011; 5: 518–525. Pu R.T., Yang J., Wasserman P.G. et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 2006; 34: 330–334.Olson M.T., Clark D.P., Erozan Y.S., Ali S.Z. Spectrum of Risk of Malignancy in Subcategories of ‘Atypia of Undetermined Significance’. Acta Cytol. 2011; 5: 518–525. Pu R.T., Yang J., Wasserman P.G. et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 2006; 34: 330–334.Renshaw A.A. Should ‘atypical follicular cells’ in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010; 118: 186–189.Renshaw A.A. Should ‘atypical follicular cells’ in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010; 118: 186–189.Sebo T.J. What are the keys to successful thyroid FNA interpretation? Clin. Endocrinol. 2012; 77: 13–17.Sebo T.J. What are the keys to successful thyroid FNA interpretation? Clin. Endocrinol. 2012; 77: 13–17.Somma J., Schlecht N.F., Fink D. et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol. 2010; 54: 123–131.Somma J., Schlecht N.F., Fink D. et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol. 2010; 54: 123–131.Theoharis C.G.A., Schofield K.M., Hammers L. et al. The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution. Thyroid. 2009; 19: 1215–1226.Theoharis C.G.A., Schofield K.M., Hammers L. et al. The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution. Thyroid. 2009; 19: 1215–1226.Van der Laan P.A., Marqusee E., Krane J.F. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am. J. Clin. Pathol. 2011; 135: 770–775.Van der Laan P.A., Marqusee E., Krane J.F. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am. J. Clin. Pathol. 2011; 135: 770–775.Van der Laan P.A., Renshaw A.A., Krane J.F. Atypia of undeter- mined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related. Am. J. Clin. Pathol. 2012; 137: 462–465.Van der Laan P.A., Renshaw A.A., Krane J.F. Atypia of undeter- mined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related. Am. J. Clin. Pathol. 2012; 137: 462–465.Wang C.C., Friedman L., Kennedy G.C. et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011; 21: 243–251.Wang C.C., Friedman L., Kennedy G.C. et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011; 21: 243–251.Yang J., Schnadig V., Logrono R., Wasserman P.G. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306–315.Yang J., Schnadig V., Logrono R., Wasserman P.G. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306–315.Yassa L., Cibas E.S., Benson C.B. et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111: 508–516.Yassa L., Cibas E.S., Benson C.B. et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111: 508–516.Gia-Khanh N., Lee M.W., Ginsberg J., Wragg T. Darcy Bilodeau Fine-needle aspiration of the thyroid: an overview. CytoJournal. 2005; 2: 12.Gia-Khanh N., Lee M.W., Ginsberg J., Wragg T. Darcy Bilodeau Fine-needle aspiration of the thyroid: an overview. CytoJournal. 2005; 2: 12.Ali S.Z., Cibas E.S., eds. Atlas "The Bethesda System for Reporting Thyroid Cytopathology". New York: Springer, 2010.Ali S.Z., Cibas E.S., eds. Atlas "The Bethesda System for Reporting Thyroid Cytopathology". New York: Springer, 2010.

The authors declare that there are no conflicts of interest present.